Vident Investment Advisory’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$34.1K Buy
2022
Q4
$108K Sell
2022
Q3
$679K Sell
2022
Q2
$875K Buy
2022
Q1
$521K Buy
2021
Q4
$1.14M Sell
2021
Q3
$1.52M Sell
2021
Q2
$1.72M Sell
2021
Q1
$2.02M Buy
2020
Q4
$1.7M Buy
2020
Q3
$1.05M Sell
2020
Q2
$1.67M Buy
2020
Q1
$1.26M Sell
2019
Q4
$2.69M Buy
2019
Q3
$756K Sell
2019
Q2
$2.02M Sell
2019
Q1
$3.71M Buy
2018
Q4
$1.83M Sell
2018
Q3
$3.43M Buy
2018
Q2
$2.59M Buy
2018
Q1
$3.19M Buy
2017
Q4
$1.56M Buy